Results 231 to 240 of about 332,502 (264)
Some of the next articles are maybe not open access.
Drug-resistant Viral Hepatitis
Journal of Infection, 2000M, Wright, J, Main, H C, Thomas
openaire +2 more sources
Expert Opinion on Investigational Drugs, 1997
Massive viral turnover and reverse transcriptase's high error rate create the potential for drug-resistant viral variants to appear rapidly under the selective pressure of antiretroviral therapy. Loss of antiviral effect in treatment-adherent persons is most commonly coincident with the appearance of viral mutants with reduced drug sensitivity.
openaire +2 more sources
Massive viral turnover and reverse transcriptase's high error rate create the potential for drug-resistant viral variants to appear rapidly under the selective pressure of antiretroviral therapy. Loss of antiviral effect in treatment-adherent persons is most commonly coincident with the appearance of viral mutants with reduced drug sensitivity.
openaire +2 more sources
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
Ca-A Cancer Journal for Clinicians, 2022Shanu Modi +2 more
exaly
Structure and Dynamics of Viral Substrate Recognition and Drug Resistance: A Dissertation
2013Drug resistance is a major problem in quickly evolving diseases, including the human immunodeficiency (HIV) and hepatitis C viral (HCV) infections. The viral proteases (HIV protease and HCV NS3/4A protease) are primary drug targets. At the molecular level, drug resistance reflects a subtle change in the balance of molecular recognition; the drug ...
openaire +2 more sources
Drug-Induced vs. Viral Maculopapular Exanthem—Resolving the Dilemma
Dermatopathology (Basel, Switzerland), 2022Rhea Ahuja, Sujay Khandpur
exaly
Drug combination therapy for emerging viral diseases
Drug Discovery Today, 2021, Zeenat Asghar Shyr
exaly
Repurposing of approved drug molecules for viral infectious diseases: a molecular modelling approach
Journal of Biomolecular Structure and Dynamics, 2022Nandan Kumar, G Narahari Sastry
exaly
Nanoformulation-based Drug Delivery System for Viral Diseases
Pharmaceutical Nanotechnology, 2023Md Aftab Alam
exaly
HIV viral resistance to antiretroviral drugs: foreword
Scandinavian Journal of Infectious Diseases, 2003openaire +2 more sources

